Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
University Children's Hospital, |
RCV000203316 | SCV000606790 | pathogenic | Methylmalonic aciduria, cblA type | criteria provided, single submitter | clinical testing | ||
Counsyl | RCV000203316 | SCV000790060 | likely pathogenic | Methylmalonic aciduria, cblA type | 2017-03-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000203316 | SCV001396170 | pathogenic | Methylmalonic aciduria, cblA type | 2023-09-13 | criteria provided, single submitter | clinical testing | Disruption of this splice site has been observed in individuals with methylmalonic aciduria (PMID: 15523652, 27858373, 28497574). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 218978). This variant is present in population databases (rs779939886, gnomAD 0.0009%). This sequence change affects a donor splice site in intron 4 of the MMAA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MMAA are known to be pathogenic (PMID: 15523652, 15781192). |
Baylor Genetics | RCV000203316 | SCV005058040 | pathogenic | Methylmalonic aciduria, cblA type | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000203316 | SCV000258480 | not provided | Methylmalonic aciduria, cblA type | no assertion provided | literature only | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001729456 | SCV001979502 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001729456 | SCV001980010 | pathogenic | not provided | no assertion criteria provided | clinical testing |